Home
Optinose

Optinose Market Share Analysis for May 2026

Optinose Site Map

Health > Biotechnology and Pharmaceuticals

Domainoptinose.com

Year Founded2000

Employees51 - 200

Annual Revenue$75M - $100M

Optinose

Optinose (including company regionals)

optinose.com

See more website traffic and engagement information

Optinose Revenue up to May 2026 is 75M - 100M

revenue generated by Optinose top domains

Optinose top domains revenue over 3 years

Revenue for Optinose top domains

optinose.com75M - 100M

See more with Sales Intelligence

Total visits to Optinose's top domains

Understand Optinose market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

optinose.com4.2K

See more with Sales Intelligence

Avg. visit duration in Optinose's top domains

Analyze Optinose engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

optinose.com00:00:30

See more with Sales Intelligence

Avg. pageviews on Optinose's top domains

See how Optinose keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

optinose.com1.84

See more with Sales Intelligence

Optinose top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Optinose

These are the website technologies, by industry, used by Optinose top domains

Audio Video Media (4)

Vimeo

Advertising (3)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Marketing (3)

Google Marketing Platform

More Technologies

9

See all

News & Signals from Optinose

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGoldan leaves OptiNose, Inc. as Chief Financial Officer.Prior to his current role, Mr. Goldan served as Chief Financial Officer of Optinose, a publicly traded specialty pharmaceutical company, where he played a key role in building the infrastructure to support the successful US launch of its lead product.

NewsOptiNose, Inc. launches XHANCE nasal spray.Optinose has introduced the XHANCE nasal spray, which uses an innovative exhalation delivery system to deposit medication deeper into the sinuses.

NewsOptiNose, Inc. hires Catherine Owen as board member.In terms of leadership changes, OptiNose announced the appointment of Terry Kohler as its new Chief Financial Officer and the resignation of board member Ms. Catherine Owen.